Mallinckrodt has completed the expansion of its operations and manufacturing facility for the investigational StrataGraft regenerative skin tissue, in Madison, WI. Stratatech, a Mallinckrodt company, recently completed patient enrollment in its ongoing pivotal Phase 3 clinical trial, which is evaluating the efficacy and safety of StrataGraft in the promotion of autologous skin regeneration of complex skin defects due to severe thermal burns that contain intact dermal elements, also known as deep...